LATEST ARTICLES
Philip J. Camp
Principal
212.257.4505
Jay J. Miele
Managing Director
212.257.4515
John P. Nero
Director
212.257.4502
Brady R. Stern
Vice President
312.508.4203
Matthew T. Tarpley
Vice President
212.257.4516
Mitchell J. Levine
Associate
212.257.4519
ATLANTA
3333 Piedmont Road
Suite 725
Atlanta, GA 30305
404.937.1350
H2C INDUSTRY INSIGHTS • REAL ESTATE
ABOUT HAMMOND HANLON CAMP LLC
Hammond Hanlon Camp LLC (“H2C”) is an independent strategic advisory and investment banking firm committed to providing superior advice as a trusted advisor to healthcare organizations and related companies throughout the United States. H2C’s professionals have a long track record of success in healthcare mergers & acquisitions, capital markets, real estate, and restructuring transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value. Hammond Hanlon Camp LLC offers securities through its wholly-owned subsidiary H2C Securities Inc., member FINRA/SIPC. For more information, go to h2c.com
REAL ESTATE INVESTMENT BANKING PRACTICE
The real estate investment banking professionals at H2C have successfully served as advisor for over 20 years on real estate transactions in excess of $12.5 billion nationwide. For more information on our real estate advisory group, please contact one of the adjacent H2C professionals.
MEDIA CONTACT
Kelly T. Duong
Hammond Hanlon Camp LLC
858.242.4810
kduong@h2c.com
NEW YORK
623 Fifth Avenue
29th Floor
New York, NY 10022
212.257.4500
CHICAGO
311 South Wacker Drive
Suite 5425
Chicago, IL 60606
312.508.4200
SAN DIEGO
4655 Executive Drive
Suite 280
San Diego, CA 92121
858.242.4800
Demand Continues to Outpace Supply
with Flurry of Activity in the Second Quarter
posted on July 31, 2019
NEW YORK — As H2C predicted in its first-quarter medical office building (“MOB”) report, the second quarter saw strong transaction volume of $3.1 billion, with 300 MOBs trading hands. A large portion of the activity was attributed to Welltower Inc.’s (“Welltower’s”) closing of the 55-property CNL Healthcare Properties (“CNL”) portfolio, which CNL put under contract in early Q1, for $1.25 billion.
With $5 billion in sales volume year to date, 2019 is on track to finish below the sales volume demonstrated in previous years. Meanwhile, MOB pricing remains similar, buoyed by a virtually flat average cap rate trend.
